Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The Optimal Management of Patients with Prostate Cancer with Oligometastatic Disease and Low Metastatic Burden in the PSMA-PET Era.
Journal: Cancers
Published: December 21, 2025
Likes and Hashtags: Exploring the Potential Relationship Between Social Media Use and the Emotional Wellbeing of Oncology Professionals.
Journal: Pediatric blood & cancer
Published: November 14, 2024
Challenges and Opportunities in Developing an Oncology Clinical Trial Network in the United States Veterans Affairs Health Care System: The VA STARPORT Experience.
Journal: Current oncology (Toronto, Ont.)
Published: June 14, 2024
Social Media and Professional Development for Oncology Professionals.
Journal: JCO oncology practice
Published: March 21, 2022
Impact of COVID-19 on Hematology-Oncology Fellowship Programs: A Quantitative and Qualitative Survey Assessment of Fellowship Program Directors.
Journal: JCO oncology practice
Published: January 11, 2022
Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment.
Journal: JCO oncology practice
Published: January 06, 2022
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study.
Journal: JMIR cancer
Published: September 27, 2021
Forming the Hematology-Oncology Collaborative Videoconferencing (CO-VID) Learning Initiative: Experiential Lessons Learned From a Novel Trainee-Led Multidisciplinary Virtual Learning Platform.
Journal: JCO oncology practice
Published: July 09, 2021
Treatment of Metastatic Carcinoma of an Unknown Primary to the Heart with Checkpoint Inhibitor Therapy.
Journal: Oncology research and treatment
Published: January 12, 2020
Penile Paget's Disease: A Case Report and Review of the Literature.
Journal: Archives of nephrology and urology
Published: January 01, 2020
Inhibition of Histone Deacetylase (HDAC) Enhances Checkpoint Blockade Efficacy by Rendering Bladder Cancer Cells Visible for T Cell-Mediated Destruction.
Journal: Frontiers in oncology
Published: December 04, 2019
Last Updated: 09/26/2026